|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Provision for losses on accounts receivable | |||||
| Non-cash stock-based compensation | |||||
| Deferred income taxes | |||||
| Amortization of debt issuance costs | |||||
| Net loss on revaluation of warrant settlement liabilities | |||||
| Net change on revaluation of earnout liabilities | |||||
| Earnout payments in excess of acquisition date fair value | |||||
| Impairment loss on long lived real estate assets | |||||
| Other adjustments | |||||
| Changes in assets and liabilities: | |||||
| Increase in accounts receivable | |||||
| (Increase) decrease in inventories | |||||
| Decrease (increase) in contract assets | |||||
| Decrease (increase) in long-term accounts receivable | |||||
| Decrease in other assets | |||||
| Increase in accounts payable | |||||
| (Decrease) increase in long-term accounts payable | |||||
| Increase (decrease) in accrued expenses and other liabilities | |||||
| Net cash provided by operating activities: | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of assets | |||||
| Purchases of property and equipment | |||||
| Acquisitions, net of cash and cash equivalents acquired | |||||
| Net cash used in investing activities: | |||||
| Cash flows from financing activities: | |||||
| Borrowings on ABL revolving credit facility | |||||
| ABL revolving credit facility | |||||
| Repayments on ABL revolving credit facility | |||||
| ABL revolving credit facility | |||||
| Warrants settlement | |||||
| Repayment of principal on the Convertible Notes | |||||
| Net borrowings (repayments) under inventory financing facilities | |||||
| Proceeds from issuance of senior unsecured notes | |||||
| Payment of debt issuance costs | |||||
| Repurchases of common stock | |||||
| Earnout and acquisition related payments | |||||
| Other payments | |||||
| Net cash provided by (used in) financing activities: | |||||
| Foreign currency exchange effect on cash, cash equivalents and restricted cash balances | |||||
| Increase (decrease) in cash, cash equivalents and restricted cash | |||||
| Cash, cash equivalents and restricted cash at beginning of period | |||||
| Cash, cash equivalents and restricted cash at end of period | |||||
Loading...